Search

MSK's 44th annual Academic Convocation and Commencement celebrated the Gerstner Sloan Kettering Graduate School of Biomedical Sciences class of 2023, honored students graduating from the Sloan Kettering Division of the Weill Cornell Medicine Graduate School of Medical Sciences, and recognized winners of several awards and fellowships.

… Friday, May 19, 2023 A record number of students graduated this year with doctoral degrees in cancer biology from the Gerstner Sloan Kettering Graduate School of Biomedical Sciences (GSK) — the educational division of Memorial Sloan Kettering Cancer Center (MSK). There were 17 graduates receiving their

Various facilities provide the services and technology that support Memorial Sloan Kettering’s cancer genomics studies.

… Wednesday, November 14, 2012 Summary Various facilities provide the services and technology that support Memorial Sloan Kettering’s cancer genomics studies. A range of facilities provide expert services and technology to support cancer genomics studies at Memorial Sloan Kettering. The Integrated Genomics

A new study is challenging the perception that mesothelioma affects only older men. Learn why MSK experts say the medical community should be aware of this rare cancer's early symptoms.

… Tuesday, March 31, 2026 Mesothelioma , a rare cancer that usually starts in the lining around the lungs, has long been thought of as a condition that affects older men — especially those who may have been exposed to asbestos while working in manufacturing or construction. About 3,300 people are diagnosed

Learn how high-intensity focused ultrasound (HIFU) can help some men with prostate cancer avoid surgery or radiation.

… Monday, June 30, 2025 For people with  prostate cancer  considered “intermediate risk” —  small tumors confined to one area of the prostate – doctors are increasingly using a treatment known as  focal therapy  (partial gland ablation). One approach uses an advanced and highly precise energy source known

Research by a team at Memorial Sloan Kettering Cancer Center has found important new insights into colorectal cancer in Nigeria that have significant implications for treating the disease in West Africa. This research also expands awareness of how different population groups may require different approaches in the diagnosis and treatment of cancer.

… Wednesday, November 24, 2021 Colorectal cancer is common — and deadly — around the world.   But too often, major population groups are not represented in colorectal cancer research, which focuses mainly on patients in America and Western Europe.   A team of researchers from Memorial Sloan Kettering Cancer

The Patient and Family Advisory Council for Quality (PFACQ) marks five years of ensuring the patient and family perspective is included in everything MSK does.

… Wednesday, January 1, 2020 In 2014, Kate Niehaus, a former patient active in volunteer work for Memorial Sloan Kettering, was approached by Kent Sepkowitz, an infectious disease specialist and Deputy Physician-in-Chief for Quality and Safety, with a proposal to make MSK’s outstanding cancer care even

Based on a clinical trial led by an MSK investigator, the FDA has approved revumenib (Revuforj®) for patients 1-year-old and older who have leukemia that has come back after treatment and whose cancer carries molecular changes called NPM1 mutations and KMT2A translocations.

… Wednesday, October 29, 2025 On October 24, 2025, the U.S. Food and Drug Administration (FDA)  approved revumenib (Revuforj ® ) for patients 1-year-old and older who have leukemia that has come back after treatment and whose cancer carries a molecular change called an NPM1 mutation. In November 2024,

Mutations that drive cancer growth also make a cell more noticeable to the immune system.

… Wednesday, May 11, 2022 Many cancers contain similar genetic “hotspots” — areas of DNA that are likely to be mutated. For example, more than 50% of cancers contain a mutation in a gene called TP53 , often within a narrow DNA range. Researchers know that hotspots can contribute to cancer development and

Get to know Abby Hawk, who got a tattoo of Memorial Sloan Kettering after being treated there for neuroblastoma.

… Friday, September 10, 2021 VIDEO | 00:04 Abby Leaves Her Mark Abby's tattoo shows the latitude and longitude of Memorial Sloan Kettering Cancer Center and the quote "The comeback is always stronger than the setback." Video Details It was a bold request. A high school senior living outside Toledo named

A lifelong smoker overcomes discomfort over what a lung cancer imaging test might reveal. She hopes her experience helps reduce the stigma for others who smoke.

… Thursday, September 19, 2024 Marylou Capes-Platt knew she was at an especially high risk for lung cancer . She had been a heavy smoker for 45 years, starting in her teens and continuing through a decades-long career in the music industry and as a writer and editor. She finally quit in 2007. But the threat